Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Zembutsu

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Stem Cells (Dayton, Ohio)|August 11, 2007
Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory functionSatoru Senju, Hirofumi Suemori, Hitoshi Zembutsu, et al.
Journal of Epidemiology|February 14, 2017
Overview of BioBank Japan follow-up data in 32 diseasesMakoto Hirata, Akiko Nagai, Yoichiro Kamatani, et al.
Plos One|August 6, 2010
Genome-wide association study of pancreatic cancer in Japanese populationSiew-Kee Low, Aya Kuchiba, Hitoshi Zembutsu, et al.
Biological & Pharmaceutical Bulletin|October 11, 2019
A Genome-Wide Association Study Identifies Five Novel Genetic Markers for Trastuzumab-Induced Cardiotoxicity in Japanese PopulationMari Hara Nakano, Chihiro Udagawa, Arata Shimo, et al.
Journal of Epidemiology|February 13, 2017
Overview of the BioBank Japan Project: Study design and profileAkiko Nagai, Makoto Hirata, Yoichiro Kamatani, et al.
Journal of Epidemiology|February 14, 2017
Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseasesMakoto Hirata, Yoichiro Kamatani, Akiko Nagai, et al.
Human Molecular Genetics|December 20, 2011
A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in JapaneseKazuma Kiyotani, Taisei Mushiroda, Tatsuhiko Tsunoda, et al.
Clinical Pharmacology and Therapeutics|February 1, 2018
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen TherapyMatthew P Goetz, Katrin Sangkuhl, Henk-Jan Guchelaar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patientsKazuma Kiyotani, Taisei Mushiroda, Chiyo K Imamura, et al.
Molecular Cancer Therapeutics|December 17, 2002
Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysisJun-ichi Okutsu, Tatsuhiko Tsunoda, Yasuyuki Kaneta, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Stem Cells (Dayton, Ohio)|August 11, 2007
Genetically manipulated human embryonic stem cell-derived dendritic cells with immune regulatory functionSatoru Senju, Hirofumi Suemori, Hitoshi Zembutsu, et al.
Journal of Epidemiology|February 14, 2017
Overview of BioBank Japan follow-up data in 32 diseasesMakoto Hirata, Akiko Nagai, Yoichiro Kamatani, et al.
Plos One|August 6, 2010
Genome-wide association study of pancreatic cancer in Japanese populationSiew-Kee Low, Aya Kuchiba, Hitoshi Zembutsu, et al.
Biological & Pharmaceutical Bulletin|October 11, 2019
A Genome-Wide Association Study Identifies Five Novel Genetic Markers for Trastuzumab-Induced Cardiotoxicity in Japanese PopulationMari Hara Nakano, Chihiro Udagawa, Arata Shimo, et al.
Journal of Epidemiology|February 13, 2017
Overview of the BioBank Japan Project: Study design and profileAkiko Nagai, Makoto Hirata, Yoichiro Kamatani, et al.
Journal of Epidemiology|February 14, 2017
Cross-sectional analysis of BioBank Japan clinical data: A large cohort of 200,000 patients with 47 common diseasesMakoto Hirata, Yoichiro Kamatani, Akiko Nagai, et al.
Human Molecular Genetics|December 20, 2011
A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in JapaneseKazuma Kiyotani, Taisei Mushiroda, Tatsuhiko Tsunoda, et al.
Clinical Pharmacology and Therapeutics|February 1, 2018
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen TherapyMatthew P Goetz, Katrin Sangkuhl, Henk-Jan Guchelaar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2010
Significant effect of polymorphisms in CYP2D6 and ABCC2 on clinical outcomes of adjuvant tamoxifen therapy for breast cancer patientsKazuma Kiyotani, Taisei Mushiroda, Chiyo K Imamura, et al.
Molecular Cancer Therapeutics|December 17, 2002
Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysisJun-ichi Okutsu, Tatsuhiko Tsunoda, Yasuyuki Kaneta, et al.
Pageof 8